CHINOLINVERBINDUNGEN

European patent · EP4089082 · In force

Register entry

Publication number
EP4089082
Application number
EP21756247
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 19, 2021
Published
Nov 16, 2022
Granted
Dec 24, 2025
Protection ends at the latest
Feb 18, 2041
Next annual fee due
Feb 28, 2027
IPC classes
C07D 401/04 (2006.01)
A61K 31/4709 (2006.01)
A61P 35/00 (2006.01)
C07D 401/14 (2006.01)
C07D 487/08 (2006.01)
A61K 31/4995 (2006.01)
A61K 31/496 (2006.01)
C07D 405/14 (2006.01)
Priority
CN 202010106990 20.02.2020
CN 202110065553 13.01.2021
PCT application
PCT/CN2021/076918 19.02.2021
PCT publication
WO2021/164742 26.08.2021
Filing language
Chinese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Dec 24, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 24.12.2025

Parties

Holder

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory

No.88, Yunxiang Road Tonghe Street Baiyun District, Guangzhou, Guangdong 510515, CN

Inventor

WANG, Jiansong

Guangzhou, Guangdong 510515, CN

ZHANG, Yang

Shanghai 200131, CN

LUO, Zhibo

Guangzhou, Guangdong 510515, CN

HUANG, Rongxin

Shanghai 200131, CN

SUN, Jikui

Shanghai 200131, CN

LI, Jie

Shanghai 200131, CN

WU, Wentao

Shanghai 200131, CN

LI, Jian

Shanghai 200131, CN

CHEN, Shuhui

Shanghai 200131, CN

BAO, Yingxia

Guangzhou, Guangdong 510515, CN

WANG, Wei

Guangzhou, Guangdong 510515, CN

XIE, Zhoufan

Guangzhou, Guangdong 510515, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.